✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹15 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
15.00 Cr
PE
PE
-
Prom Holding
Prom Holding
30.80 %
ROE (%)
ROE (%)
-8,146.37
ROCE (%)
ROCE (%)
-82.25
Div Yield (%)
Div Yield (%)
-
Sales
Sales
28.20 Cr
OPM (%)
OPM (%)
0.90 %
Debt to Equity
Debt to Equity
83.26
About
Parmax Pharma Limited is a pharmaceutical company specializing in active pharmaceutical ingred… Read more
Low
29
52W Range
High
55
  • Parmax Pharma
  • Saroja Pharma Ind
  • iStreet Network

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Parmax Pharma Ltd. Business

Parmax Pharma Limited excels in producing active pharmaceutical ingredients (API) and providing Contract Manufacturing Operations (CMO) with a strong emphasis on quality by design methods in compliance with cGMP standards.

Parmax Pharma major competitors are iStreet Network, Venmax Drugs&Pharma, Saroja Pharma Ind, Emmessar Biotech&Nut, Decipher Labs, Hamps Bio, Chemo Pharma Labs.
Market Cap of Parmax Pharma is ₹15 Crs.
While the median market cap of its peers are ₹15 Crs.

Parmax Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Parmax Pharma is -0.48 and is ranked 7 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material